Meadow Creek Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Meadow Creek Wealth Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$283K	Sell	4,915 -3,189	-39%	-$183K	0.17%	113
2026 Q1	$492K	Buy	8,104 +846	+12%	+$49.3K	0.32%	65
2025 Q4	$391K	Sell	7,258 -747	-9%	-$35.9K	0.25%	80
2025 Q3	$347K	Sell	8,005 -521	-6%	-$24.3K	0.23%	89
2025 Q2	$395K	Sell	8,526 -13	-0.2%	-$638	0.27%	77
2025 Q1	$521K	Buy	8,539 +57	+0.7%	+$3.32K	0.39%	58
2024 Q4	$480K	Buy	8,482 +2,537	+43%	+$142K	0.35%	62
2024 Q3	$308K	Hold	5,945	–	–	0.24%	97
2024 Q2	$247K	Hold	5,945	–	–	0.23%	103
2024 Q1	$322K	Buy	5,945 +1,616	+37%	+$82.3K	0.22%	103
2023 Q4	$222K	Buy	+4,329	New	+$227K	0.22%	96
2022 Q3	$242K	Buy	3,405 +69	+2%	+$5K	0.32%	79
2022 Q2	$257K	Hold	3,336	–	–	0.32%	80
2022 Q1	$244K	Hold	3,336	–	–	0.26%	96
2021 Q4	$208K	Buy	+3,336	New	+$196K	0.2%	118
2019 Q4	$217K	Buy	+3,380	New	+$194K	0.3%	87

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Meadow Creek Wealth Advisors's BMY Position: Q2 2026 in Review

Meadow Creek Wealth Advisors reduced its Bristol-Myers Squibb (BMY) stake by 39% in Q2 2026, selling an estimated $183K and leaving 4,915 shares worth $283K. The position accounts for 0.17% of the portfolio, ranked #113.

Meadow Creek Wealth Advisors first reported a position in BMY in Q4 2019 and has held it in 16 quarters since. The position peaked at $521K in Q1 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Meadow Creek Wealth Advisors held 4,915 shares of Bristol-Myers Squibb worth $283K as of Q2 2026.
Meadow Creek Wealth Advisors sold 3,189 Bristol-Myers Squibb shares in Q2 2026, an estimated $183K.
Bristol-Myers Squibb made up 0.17% of Meadow Creek Wealth Advisors's portfolio in Q2 2026, its #113 holding.
Meadow Creek Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 16 quarters since.
Meadow Creek Wealth Advisors's Bristol-Myers Squibb position peaked at $521K in Q1 2025.
2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Meadow Creek Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.